Yahoo
NYSEArca - Delayed Quote USD

Capital Group Global Growth Equity ETF (CGGO)

40.57 +0.33 (+0.82%)
At close: September 4 at 4:00:00 PM EDT
40.25 -0.32 (-0.79%)
After hours: September 4 at 7:59:25 PM EDT
Trade CGGO on Coinbase
Chart Range Bar
Loading chart for CGGO
  • Previous Close 40.24
  • Open 40.27
  • Bid 40.57 x 220000
  • Ask 42.00 x 190000
  • Day's Range 40.27 - 40.59
  • 52 Week Range 31.94 - 42.88
  • Volume 975,057
  • Avg. Volume 1,241,114
  • Net Assets 11.9B
  • NAV 40.40
  • PE Ratio (TTM) 22.80
  • Yield 0.99%
  • YTD Daily Total Return 17.09%
  • Beta (5Y Monthly) 1.18
  • Expense Ratio (net) 0.47%

The fund invests primarily in common stocks of companies around the world that the investment adviser believes have the potential for growth. The fund normally invests at least 80% of its assets in equity securities. As a fund that seeks to invest globally, the fund will allocate its assets among securities of companies in various countries, including the United States and countries with emerging markets (but in no fewer than three countries). Under normal market conditions, the fund will invest a percentage of its net assets outside the United States. It is non-diversified.

Capital Group

Fund Family

Global Large-Stock Growth

Fund Category

11.9B

Net Assets

2022-02-22

Inception Date

Performance Overview

View More

Trailing returns as of 9/4/2026. Category is Global Large-Stock Growth.

YTD Return

CGGO
17.09%
Category
2.61%

1-Year Return

CGGO
25.21%
Category
20.81%

3-Year Return

CGGO
20.21%
Category
16.48%

People Also Watch

Holdings

View More

Top 10 Holdings (31.05% of Total Assets)

Symbol Company % Assets
Taiwan Semiconductor Manufacturing Company Limited 6.71%
Micron Technology, Inc. 3.59%
Alphabet Inc. 3.41%
Broadcom Inc. 3.39%
SK Hynix Inc 3.11%
ASML Holding N.V. 2.54%
Western Digital Corporation 2.35%
Samsung Electronics Co Ltd 2.24%
Microsoft Corporation 2.07%
3i Group Ord 1.64%

Sector Weightings

Research Reports

View More
  • Daily – Vickers Top Insider Picks for 09/03/2026

    The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.

  • Boston Scientific Earnings: Competitive Pressure Closing in on Key Growth Areas

    Boston Scientific focuses on less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.

    Rating
    Price Target
  • Raising target price and EPS estimates on outlook

    Johnson & Johnson is a diversified global healthcare company that develops, manufactures, and markets products in two business segments: Innovative Medicine (formerly Pharmaceuticals) and MedTech.

    Rating
    Price Target
  • Johnson & Johnson Earnings: Steady Growth and Good Near-Term Visibility; Maintaining Our FVE

    Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of the total revenue is generated in the United States.

    Rating
    Price Target

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: